VistaGen Therapeutics Financial Health
How is VistaGen Therapeutics's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: VTGN's short term assets ($26.1M) exceed its short term liabilities ($4.3M).
Long Term Liabilities: VTGN's short term assets ($26.1M) exceed its long term liabilities ($4.7M).
Debt to Equity History and Analysis
Debt Level: VTGN has more cash than its total debt.
Reducing Debt: VTGN's debt to equity ratio has increased from 0.3% to 2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VTGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VTGN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.7% each year